KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Depreciation and Depletion (2016 - 2025)

AbbVie (ABBV) has disclosed Depreciation and Depletion for 14 consecutive years, with $203.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion fell 1.46% to $203.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $762.0 million through Dec 2025, changed 0.26% year-over-year, with the annual reading at $762.0 million for FY2025, 0.26% changed from the prior year.
  • Depreciation and Depletion for Q4 2025 was $203.0 million at AbbVie, up from $192.0 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $223.0 million in Q3 2021, with the low at $173.0 million in Q4 2021.
  • Average Depreciation and Depletion over 5 years is $193.0 million, with a median of $191.5 million recorded in 2024.
  • Peak annual rise in Depreciation and Depletion hit 79.13% in 2021, while the deepest fall reached 23.79% in 2021.
  • Over 5 years, Depreciation and Depletion stood at $173.0 million in 2021, then rose by 13.29% to $196.0 million in 2022, then fell by 4.59% to $187.0 million in 2023, then rose by 10.16% to $206.0 million in 2024, then fell by 1.46% to $203.0 million in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $203.0 million, $192.0 million, and $186.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.